Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Tumor targeting by a multivalent single-chain Fv (scFv) anti-Lewis Y antibody construct.

Kelly MP, Lee FT, Tahtis K, Power BE, Smyth FE, Brechbiel MW, Hudson PJ, Scott AM.

Cancer Biother Radiopharm. 2008 Aug;23(4):411-23. doi: 10.1089/cbr.2007.0450.

2.
3.

Soluble Robo4 receptor inhibits in vivo angiogenesis and endothelial cell migration.

Suchting S, Heal P, Tahtis K, Stewart LM, Bicknell R.

FASEB J. 2005 Jan;19(1):121-3. Epub 2004 Oct 14.

PMID:
15486058
4.

Expression and targeting of human fibroblast activation protein in a human skin/severe combined immunodeficient mouse breast cancer xenograft model.

Tahtis K, Lee FT, Wheatley JM, Garin-Chesa P, Park JE, Smyth FE, Obata Y, Stockert E, Hall CM, Old LJ, Rettig WJ, Scott AM.

Mol Cancer Ther. 2003 Aug;2(8):729-37.

5.

Construction, expression and characterisation of a single-chain diabody derived from a humanised anti-Lewis Y cancer targeting antibody using a heat-inducible bacterial secretion vector.

Power BE, Caine JM, Burns JE, Shapira DR, Hattarki MK, Tahtis K, Lee FT, Smyth FE, Scott AM, Kortt AA, Hudson PJ.

Cancer Immunol Immunother. 2001 Jul;50(5):241-50.

PMID:
11499807
6.

Supplemental Content

Loading ...
Support Center